IMNN

Imunon Inc

• Benzinga·10/01 21:06

  12 Health Care Stocks Moving In Thursday's After-Market Session

• TipRanks·09/29 12:29

  Imunon Introduces Series B Preferred to Restructure Debt

• NASDAQ·09/26 16:47

  IMUNON Reports Positive IDMC Opinion For IMNN-001 In Ovarian Cancer

• TipRanks·09/25 08:10

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Imunon (IMNN)

• NASDAQ·09/24 13:59

  IMUNON Highlights 14.7-Month Survival Benefit For IMNN-001; OVATION 3 Enrollment Ahead Of Plan

• TipRanks·09/24 12:20

  Imunon presents update on its IMNN-001 development program

• Benzinga·09/24 12:10

  IMUNON Reports Overall Survival Results, Advances Phase 3 OVATION 3 Trial

• TipRanks·09/22 12:37

  Imunon announces IDMC recommends continued Phase 2 development of IMNN-001

• Benzinga·09/22 12:10

  IMUNON Says Independent Monitoring Committee Recommends Continuing IMNN-001 Phase 2 Study Without Modification

• TipRanks·09/10 13:40

  Imunon enters CRADA with National Cancer Institute for IMNN-001 development

• Benzinga·09/10 13:31

  IMUNON Enters Into CRADA With National Cancer Institute To Advance DNA-Based IL‑12 Immunotherapy IMNN‑001

• Benzinga·09/10 12:06

  12 Health Care Stocks Moving In Thursday's Pre-Market Session

• Benzinga·09/09 12:31

  IMUNON To Discuss OVATION 1 Clinical Study At Its Sept. 23 R&D Day

• TipRanks·08/23 00:29

  Imunon Earnings Call Highlights Survival Gains, Cash Needs

• TipRanks·08/12 17:15

  Imunon: Buy Rating Reiterated as Phase 3 IMNN-001 Progress and Extended Cash Runway Support Unchanged $10 Price Target